Medications to Avoid in Children with G6PD Deficiency
Primaquine must be absolutely avoided in children with G6PD deficiency as it causes severe, potentially life-threatening hemolysis 1. Beyond primaquine, the evidence-based list of medications requiring strict avoidance is surprisingly limited.
High-Risk Medications - AVOID
Based on the strongest available evidence, the following medications should be strictly avoided in G6PD-deficient children:
- Primaquine - Causes severe hemolysis; explicitly contraindicated in guidelines 1
- Rasburicase - High risk of acute hemolytic crisis 2, 3, 4, 5
- Dapsone - Solid evidence of hemolysis risk 6, 2, 3
- Methylene blue (methylthioninium chloride) - Paradoxically worsens methemoglobinemia and causes hemolysis in G6PD deficiency 7, 2, 3
- Nitrofurantoin - Established hemolysis risk 2, 3, though real-world data shows it has been used safely in some cases 8
- Phenazopyridine - Evidence supports avoidance 2, 3, 4
Critical Clinical Considerations
Primaquine-Specific Guidance
The guidelines explicitly state that primaquine should not be administered for greater than 5 days in populations where severe G6PD deficiency is common (notably among Asians), as administration for longer periods may result in life-threatening hemolysis 9. Whenever possible, persons needing primaquine should first have a blood test for G6PD deficiency 1.
Methylene Blue Warning
Methylene blue should be avoided in patients with G6PD deficiency 7. In G6PD-deficient patients, MB may induce hemolysis and paradoxically worsen methemoglobinemia because these patients cannot produce sufficient NADPH to reduce methylene blue to its therapeutic form (leukomethylene blue). In an emergency, a family history of G6PD deficiency should be sought before MB therapy is instituted 7.
Alternative Treatments When High-Risk Drugs Are Needed
- For methemoglobinemia in G6PD-deficient patients: Use ascorbic acid instead of methylene blue 7
- For PCP treatment: Clindamycin/primaquine is contraindicated in G6PD deficiency due to the primaquine component 6
Medications Previously Suspected But Likely Safe
Recent high-quality evidence 2, 3, 8, 10 demonstrates that many medications historically avoided can actually be used safely:
- Quinolones (ciprofloxacin, ofloxacin) - Large real-world study showed no increased hemolysis risk 8, 10
- Sulfamethoxazole/cotrimoxazole - Used safely in thousands of G6PD-deficient patients 8
- Sulfasalazine - Real-world evidence supports safety 8
- Hydroxychloroquine - No evidence of hemolysis in practice 8
Common Pitfalls to Avoid
Over-restriction: Many medications have been wrongly cited as causing hemolysis because they were administered during infection-related hemolytic episodes, not because the drug itself caused hemolysis 2
Testing timing: G6PD enzymatic testing may be unreliable during hyperleukocytosis or shortly after blood transfusions 5. Consider genetic testing via whole exome sequencing for definitive diagnosis in these situations.
Infection as trigger: Remember that infections themselves can trigger hemolysis in G6PD-deficient patients 8. The most common cause of major hemolysis requiring hospitalization is fava bean ingestion (71.8% of cases), followed by infections (8.5%), with medications causing only 4.2% of cases 8.
Pregnancy considerations: Primaquine should not be used during pregnancy as it may be passed transplacentally to a G6PD-deficient fetus and cause hemolytic anemia in utero 1.
Monitoring Recommendations
When any potentially oxidative medication must be used in a G6PD-deficient child: